South & Central America Colorectal Cancer Market Forecast to 2028

Report Code : BMIRE00026291 | Region : LAMEA | Industry : Pharmaceuticals | Published Date : 23/Sep/2022
South & Central America Colorectal Cancer Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Modality (Diagnosis Type, Therapy Type, and Imaging Type) and End User (Hospitals and Diagnostic & Research Laboratories)

The colorectal cancer market in South & Central America is expected to grow from US$ 681.70 million in 2022 to US$ 814.50 million by 2028; it is estimated to grow at a CAGR of 2.2% from 2022 to 2028.

The market for colorectal cancer in the region is expected to grow owing to rise in the incidences of colorectal cancer and increase in the demand for colonoscopy procedures in Brazil. The market is also attributed to grow in Argentina due to the rising advancement for the technology to prevent incidences of the cancers.

The Rest of South & Central America colorectal cancer market is segmented into Chile, Peru, Ecuador, and other countries. According to GLOBOCAN 2020 data, there were approximately 6,219 new colorectal cancer cases in Chile, representing 11.5% of all new cancer cases in both genders, and ~4,636 new colorectal cancer cases were diagnosed in all ages in Peru.

Moreover, the majority of the countries in Latin America lack adequate systematic screening or prevention programs. The general screening of people aged above 50 years is a cost-effective and efficacious way of reducing colorectal cancer. Several South & Central American countries have developed national guidelines for early detection, management, and follow-up of colorectal cancer. Further, Uruguay has implemented colorectal cancer screening programs, while Chile, Cuba, and Ecuador have initiated pilot studies.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the South & Central America colorectal cancer market at a substantial CAGR during the forecast period.

South & Central America Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)

South & Central America Colorectal Cancer Market Segmentation

The South & Central America colorectal cancer market is segmented into modality, and end user, and country. Based on modality, the global colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. In 2022, the diagnosis type segment holds the largest market share and is expected to register the highest CAGR during the forecast period. Based on end user, the global colorectal cancer market is bifurcated into hospitals and diagnostic & research laboratories. In 2022, the hospitals segment holds a larger market share. Based on country, the South & Central America colorectal cancer market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America held the largest market share in 2022.

Abbott, Amgen Inc., Bruker Corporation, Clinical Genomics Technologies Pty Ltd., EDP Biotech Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics, and VolitionRx Limited are among the leading companies operating in the South & Central America colorectal cancer market.

The List of Companies - South & Central America Colorectal Cancer Market

● Abbott

● Amgen Inc.

● Bruker Corporation

● Epigenomics AG

● F. Hoffmann-La Roche AG

● Quest Diagnostics  

● VolitionRx Limited

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 SAM Colorectal Cancer Market – By Modality

1.3.2 SAM Colorectal Cancer Market – By End User

1.3.3 SAM Colorectal Cancer Market – By Country

2. SAM Colorectal Cancer Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. SAM Colorectal Cancer– Market Landscape

4.1 Overview

4.2 SAM PEST Analysis

4.2.1 SAM Colorectal Cancer Market –PEST Analysis

4.3 Expert Opinion

5. SAM Colorectal Cancer Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Colorectal Cancer

5.1.2 New Product Launches

5.1.3 Benefits Offered by Generic Drugs

5.2 Market Restraints

5.2.1 Pricing Pressure on Drug Manufacturers

5.3 Future Trends

5.3.1 Inclination Toward Personalized Medicine

5.4 Impact Analysis

6. SAM Colorectal Cancer Market– SAM Analysis

6.1 SAM Colorectal Cancer Market Revenue Forecast and Analysis

6.1.1 Overview

7. SAM Colorectal Cancer Market Analysis – By Modality

7.1 Overview

7.2 SAM Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%)

7.3 Diagnosis Type

7.3.1 Overview

7.3.2 Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3 Immunohistochemistry

7.3.3.1 Overview

7.3.3.2 Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4 Stool Test

7.3.4.1 Overview

7.3.4.2 Stool Test : Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5 Flexible Sigmoidoscopy

7.3.5.1 Overview

7.3.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.6 Colonoscopy

7.3.6.1 Overview

7.3.6.2 Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.7 CEA Test

7.3.7.1 Overview

7.3.7.2 CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.3.8 Other Test

7.3.8.1 Overview

7.3.8.2 Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Therapy Type

7.4.1 Overview

7.4.2 SAM Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Chemotherapy

7.4.3.1 Overview

7.4.3.2 Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3.3 Alkylating Agent

7.4.3.3.1 Overview

7.4.3.3.2 Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3.4 Antimetabolites

7.4.3.4.1 Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3.5 Others

7.4.3.5.1 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Immunotherapy

7.4.4.1 Overview

7.4.4.2 Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4.3 Panitumumab

7.4.4.3.1 Overview

7.4.4.3.2 Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4.4 Cetuximab

7.4.4.4.1 Overview

7.4.4.4.2 Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4.5 Bevacizumab

7.4.4.5.1 Overview

7.4.4.5.2 Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4.6 Others

7.4.4.6.1 Overview

7.4.4.6.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Chemoprotectant

7.4.5.1 Overview

7.4.5.2 Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.4.6 Others

7.4.6.1 Overview

7.4.6.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Imaging Type

7.5.1 Overview

7.5.2 SAM Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.5.3 Computed Tomography (CT)

7.5.3.1 Overview

7.5.3.2 Computed Tomography (CT): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.5.4 Magnetic Resonance Imaging (MRI)

7.5.4.1 Overview

7.5.4.2 Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

7.5.5 Others

7.5.5.1 Overview

7.5.5.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

8. SAM Colorectal Cancer Market Revenue and Forecast To 2028 – By End User

8.1 Overview

8.2 SAM Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Diagnostic and Research Laboratories

8.4.1 Overview

8.4.2 Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

9. SAM Colorectal Cancer Market Revenue and Forecast to 2028 – Country Analysis

9.1 Overview

9.1.1 SAM: Colorectal Cancer Market Share, by Country (2022 & 2028) (%)

9.1.1.1 Brazil: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.1 Brazil: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.1.2 Brazil: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

9.1.1.1.2.1 Brazil: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)

9.1.1.1.2.2 Brazil: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)

9.1.1.1.2.2.1 Brazil: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)

9.1.1.1.2.2.2 Brazil: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)

9.1.1.1.2.3 Brazil: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)

9.1.1.1.3 Brazil: Colorectal Cancer Market – Revenue and Forecast to 2028, By End Users (US$ Million)

9.1.1.2 Argentina: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.1 Argentina: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.2.2 Argentina: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

9.1.1.2.2.1 Argentina: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)

9.1.1.2.2.2 Argentina: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)

9.1.1.2.2.2.1 Argentina: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)

9.1.1.2.2.2.2 Argentina: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)

9.1.1.2.2.3 Argentina: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)

9.1.1.2.3 Argentina: Colorectal Cancer Market – Revenue and Forecast to 2028, By End Users (US$ Million)

9.1.1.3 Rest of SAM: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.1 Rest of SAM: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)

9.1.1.3.2 Rest of SAM: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

9.1.1.3.2.1 Rest of SAM: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)

9.1.1.3.2.2 Rest of SAM: Colorectal Cancer Market, by Therapy Type – 2019- 2028 (US$ Million)

9.1.1.3.2.2.1 Rest of SAM: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)

9.1.1.3.2.2.2 Rest of SAM: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)

9.1.1.3.2.3 Rest of SAM: Colorectal Cancer Market, by Imaging Type – 2019–2028 (US$ Million)

9.1.1.3.3 Rest of SAM: Colorectal Cancer Market – Revenue and Forecast to 2028, By End Users (US$ Million)

10. Colorectal Cancer Market – Industry Landscape

10.1 Overview

10.2 Growth Strategies In The Colorectal Cancer Market, 2022-2028

10.3 Organic Developments

10.3.1 Overview

10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028

10.4 Inorganic Developments

10.4.1 Overview

10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028

11. Company Profiles

11.1 Epigenomics AG

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Abbott

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Amgen Inc.

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 F. HOFFMANN-LA ROCHE LTD.

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Bruker Corporation

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Quest Diagnostics Incorporated

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Volitionrx Limited

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES.

Table 1.             SAM Colorectal Cancer Market Share, by Country (2022 & 2028) (%)

Table 2.             Brazil: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

Table 3.             Brazil: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Brazil: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Brazil: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Brazil: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Brazil: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Brazil: Colorectal Cancer Market – Revenue and Forecast to 2028, By End User (US$ Million)

Table 9.             Argentina: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

Table 10.          Argentina: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Argentina: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Argentina: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Argentina: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Argentina: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Argentina: Colorectal Cancer Market – Revenue and Forecast to 2028, By End Users (US$ Million)

Table 16.          Rest of SAM: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)

Table 17.          Rest of SAM: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of SAM: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Rest of SAM: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Rest of SAM: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Rest of SAM: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Rest of SAM: Colorectal Cancer Market – Revenue and Forecast to 2028, By End Users (US$ Million)

Table 23.          Recent Organic Growth Strategies In The Colorectal Cancer Market

Table 24.          Recent Inorganic Growth Strategies In The Colorectal Cancer Market

Table 25.          Glossary of Terms, SAM Colorectal Cancer Market

The List of Companies - South & Central America Colorectal Cancer Market

● Abbott

● Amgen Inc.

● Bruker Corporation

● Epigenomics AG

● F. Hoffmann-La Roche AG

● Quest Diagnostics  

● VolitionRx Limited

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South & Central America colorectal cancer market

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the South & Central America colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the colorectal cancer market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(South & Central America Colorectal Cancer Market Forecast to 2028)
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry